Journal of Resource Management and Decision Engineering 3 Serial Number 9 2024 11 25 The Analysis of Scenario Simulations of Smart Pharmaceutical Distribution Model in the Pharmaceutical Supply Chain Industry The Analysis of Scenario Simulations of Smart Pharmaceutical Distribution Model in the Pharmaceutical Supply Chain Industry 151 168 10.61838/kman.jrmde.3.4.15 EN Journal Article 2024 09 01 <p>This study aimed to analyze the effects of governance, network, technology, member, data, service, and demand-related factors on the performance of smart pharmaceutical distribution systems using agent-based simulation. The research employed a mixed-method design combining library studies, expert interviews, and Delphi analysis to identify key factors affecting pharmaceutical supply chain performance. Data were gathered from Tofigh Daru Company through semi-structured interviews and Delphi surveys involving ten experts, and analyzed using content analysis and Delphi consensus. Subsequently, agent-based simulation was conducted using NetLogo to assess the effects of identified factors and their scenarios on system performance metrics including cost reduction, delivery efficiency, and resilience. Results showed that governance-related factors had the highest overall initial impact on distribution performance, followed by member-related and demand-related factors, although their effects plateaued over time. Data-related factors demonstrated the most sustained and linear positive impact on performance. Network, technology, and service-related factors showed significant but gradually stabilizing effects. Simulation of scenario increases in each factor category revealed that governance, data, and member factors led to the largest performance gains, underscoring the need for multi-factorial integration in system design. Smart pharmaceutical distribution performance is driven by the synergistic interaction of governance structures, technological readiness, robust data systems, skilled members, and adaptive demand strategies. Building resilient, transparent, and efficient pharmaceutical supply chains requires balancing these dimensions, supported by continuous innovation, effective policy frameworks, and workforce development.</p> https://journalrmde.com/index.php/jrmde/article/download/84/84